BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19920092)

  • 21. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.
    Linn-Rasker SP; van der Helm-van Mil AH; van Gaalen FA; Kloppenburg M; de Vries RR; le Cessie S; Breedveld FC; Toes RE; Huizinga TW
    Ann Rheum Dis; 2006 Mar; 65(3):366-71. PubMed ID: 16014670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
    Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
    Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
    Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
    Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
    J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
    Laki J; Lundström E; Snir O; Rönnelid J; Ganji I; Catrina AI; Bengtsson C; Saevarsdottir S; Wick MC; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2012 Jul; 64(7):2078-84. PubMed ID: 22307773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.
    Lee HS; Irigoyen P; Kern M; Lee A; Batliwalla F; Khalili H; Wolfe F; Lum RF; Massarotti E; Weisman M; Bombardier C; Karlson EW; Criswell LA; Vlietinck R; Gregersen PK
    Arthritis Rheum; 2007 Jun; 56(6):1745-53. PubMed ID: 17530703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles.
    Verpoort KN; Papendrecht-van der Voort EA; van der Helm-van Mil AH; Jol-van der Zijde CM; van Tol MJ; Drijfhout JW; Breedveld FC; de Vries RR; Huizinga TW; Toes RE
    Arthritis Rheum; 2007 Sep; 56(9):2913-8. PubMed ID: 17763436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives.
    El-Gabalawy HS; Robinson DB; Hart D; Elias B; Markland J; Peschken CA; Smolik I; Montes-Aldana G; Schroeder M; Fritzler MJ; Cheang M; Oen K
    J Rheumatol; 2009 Jun; 36(6):1130-5. PubMed ID: 19411392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.
    Tamai M; Kawakami A; Iwamoto N; Arima K; Aoyagi K; Eguchi K
    Scand J Rheumatol; 2010 Aug; 39(4):287-91. PubMed ID: 20476860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of HLA-DRB alleles on the subclass titres of antibodies against citrullinated peptides.
    Engelmann R; Eggert M; Neeck G; Mueller-Hilke B
    Rheumatology (Oxford); 2010 Oct; 49(10):1862-6. PubMed ID: 20584722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
    Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
    Verpoort KN; van Gaalen FA; van der Helm-van Mil AH; Schreuder GM; Breedveld FC; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
    Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
    J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
    Bang SY; Lee HS; Lee KW; Bae SC
    J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.
    Montes A; Dieguez-Gonzalez R; Perez-Pampin E; Calaza M; Mera-Varela A; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2011 Mar; 63(3):654-61. PubMed ID: 21360494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
    Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
    Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.